This website has been developed by Besins Healthcare (UK) Ltd. This website has separate sections for healthcare professionals and patients who have been prescribed Testogel® 16.2 mg/g gel, within the UK.

Besins Healthcare is a pharmaceutical company specialising in the development of innovative drugs for the well-being of men and women throughout their life.

This website is provided for HCPs in the UK by Besins Healthcare (UK) Ltd.

AMS Scale

AMS Scale

The Ageing Males’ Symptoms (AMS) scale is a short questionnaire that can assess whether your patients are experiencing symptoms of testosterone deficiency. It can also be used to assess changes in symptom severity in patients treated with testosterone therapy.1

You can fill out the questionnaire below on behalf of your patient, or alternatively, patients can complete a patient version.

Answer
0 of 17

Question one

Decline in their feeling of general well-being

(General state of health, subjective feeling)

Question two

Joint pain and muscular ache

(Lower back pain, joint pain, pain in a limb, general back ache)

Question three

Excessive sweating

(Unexpected/sudden episodes of sweating, hot flushes independent of strain)

Question four

Sleep problems

(Difficulty in falling asleep, difficulty in sleeping through, waking up early and feeling tired, poor sleep, sleeplessness)

Question five

Increased need for sleep, often feel tired

Question six

Irritability

(Feeling aggressive, easily upset about little things, moody)

Question seven

Nervousness

(Inner tension, restlessness, feeling fidgety)

Question eight

Anxiety

(Feeling panicky)

Question nine

Physical exhaustion/lacking vitality

(General decrease in performance, reduced activity, lacking interest in leisure activities, feeling of getting less done, of achieving less, of having to force oneself to undertake activities)

Question ten

Decrease in muscular strength

(Feeling of weakness)

Question eleven

Depressive mood

(Feeling down, sad, on the verge of tears, lack of drive, mood swings, feeling nothing is of any use)

Question twelve

Your patient feeling as if they have passed their peak

Question thirteen

Feeling burnt out, having hit rock-bottom

Question fourteen

Decrease in beard growth

Question fifteen

Decreased ability/frequency to perform sexually

Question sixteen

Decrease in the number of morning erections

Question seventeen

Decrease in sexual desire/libido

(Lacking pleasure in sex, lacking desire for sexual intercourse)

Understanding your patient’s AMS scale result2

Your patient’s Ageing Males’ Symptoms (AMS) score is

Understanding your patient’s result2

Your patient has no symptoms which indicate TD.

Understanding your patient’s AMS scale result2

Your patient’s Ageing Males’ Symptoms (AMS) score is

Understanding your patient’s result2

Your patient has mild symptoms associated with TD.

Understanding your patient’s AMS scale result2

Your patient’s Ageing Males’ Symptoms (AMS) score is

Understanding your patient’s result2

Your patient has moderate symptoms associated with TD.

Understanding your patient’s AMS scale result2

Your patient’s Ageing Males’ Symptoms (AMS) score is

Understanding your patient’s result2

Your patient has severe symptoms associated with TD.

Total score  
<26 No/little complaints
27-36 Mild
37-49 Moderate
50+ Severe

Save your patient’s results

You may want to print out this questionnaire to discuss the results in detail with your patient.

Support patient self-management with the T Track app

Encourage your patients to download the T Tack app to track their own symptoms and progress, as well as get all the information they need on their Testogel® 16.2mg/g gel treatment.

T Track app available for both iOS and Android phones.

Support patient self-management with the T Track app

References

  1. Heinemann L, Saad F, Zimmermann T, et al. The Aging Males’ Symptoms (AMS) Scale: Update and compilation of international versions. Health Qual Life Outcomes. 2003;1:15.
  2. Moore C, Huebler D, Zimmermann T, et al. The Aging Males’ Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol. 2004;46(1):80–87.

TES/2020/009. April 2021.

Adverse event reporting

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Besins Healthcare (UK) Ltd Drug Safety on 0203 862 0920 or Email: pharmacovigilance@besins-healthcare.com